We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.28%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.82B
AUM Growth
+$324M
Cap. Flow
-$120M
Cap. Flow %
-6.62%
Top 10 Hldgs %
36.31%
Holding
2,419
New
1,036
Increased
430
Reduced
305
Closed
497

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Consumer Discretionary 5.02%
3 Healthcare 3.42%
4 Financials 2.97%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEVA icon
1701
CEVA Inc
CEVA
$889M
$5K ﹤0.01%
+133
New +$4.26K
DVAX
1702
CALL
DELISTED
Dynavax Technologies
DVAX
$5K ﹤0.01%
+600
New +$3.03K
GERN icon
1703
CALL
Geron
GERN
$949M
$5K ﹤0.01%
2,500
+1,300
+108% +$1.94K
GMS
1704
DELISTED
GMS Inc
GMS
$5K ﹤0.01%
200
GPRO icon
1705
PUT
GoPro
GPRO
$121M
$5K ﹤0.01%
+1,000
New +$3.79K
GSIT icon
1706
GSI Technology
GSIT
$255M
$5K ﹤0.01%
639
-1,039
-62% -$7.54K
IAU icon
1707
CALL
iShares Gold Trust
IAU
$65.1B
$5K ﹤0.01%
150
IQ icon
1708
PUT
iQIYI
IQ
$1.31B
$5K ﹤0.01%
200
JWN
1709
PUT
DELISTED
Nordstrom
JWN
$5K ﹤0.01%
+300
New +$5.28K
NC icon
1710
NACCO Industries
NC
$312M
$5K ﹤0.01%
200
NINE
1711
DELISTED
Nine Energy Service
NINE
$5K ﹤0.01%
+2,453
New +$4.12K
OFG icon
1712
OFG Bancorp
OFG
$2.2B
$5K ﹤0.01%
362
SBH icon
1713
Sally Beauty Holdings
SBH
$1.57B
$5K ﹤0.01%
+394
New +$4.31K
SQQQ icon
1714
CALL
ProShares UltraPro Short QQQ
SQQQ
$1.75B
$5K ﹤0.01%
1
SYBX
1715
DELISTED
Synlogic
SYBX
$5K ﹤0.01%
+156
New +$4.99K
TWI icon
1716
Titan International
TWI
$457M
$5K ﹤0.01%
+3,349
New +$4.5K
XGN icon
1717
Exagen
XGN
$161M
$5K ﹤0.01%
417
CBAY
1718
CALL
DELISTED
Cymabay Therapeutics
CBAY
$5K ﹤0.01%
+1,500
New +$4.33K
CEQP
1719
CALL
DELISTED
Crestwood Equity Partners LP
CEQP
$5K ﹤0.01%
+400
New +$4.56K
ACOR
1720
DELISTED
Acorda Therapeutics
ACOR
$5K ﹤0.01%
+53
New +$5.6K
ELVT
1721
DELISTED
Elevate Credit, Inc.
ELVT
$5K ﹤0.01%
+3,044
New +$5.32K
CHRA
1722
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$5K ﹤0.01%
+147
New +$2.55K
BXRX
1723
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$5K ﹤0.01%
+1
New +$4.8K
HPR
1724
DELISTED
HighPoint Resources Corporation
HPR
$5K ﹤0.01%
+328
New +$4.76K
CRC
1725
PUT
DELISTED
California Resources Corporation
CRC
$5K ﹤0.01%
3,800
-600
-14% -$1.01K

Similar funds

Prelude Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Prelude Capital Management held 2,419 positions worth $1.82B, up 22% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Prelude Capital Management withdrew a net $120M in Q2 2020, closing 497 positions and reducing 305 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in iShares 0-5 Year High Yield Corporate Bond ETF worth $24.4M.

  • Prelude Capital Management's largest Q2 2020 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 568,440 shares worth $24.4M.
  • Prelude Capital Management added most to Acacia Communications Inc in Q2 2020, an estimated $3.72M increase.
  • Prelude Capital Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $8.71M.
  • Prelude Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.1M.
  • Prelude Capital Management's ten largest holdings make up 36% of its $1.82B portfolio in Q2 2020.
  • Prelude Capital Management opened 1,036 new positions and closed 497 in Q2 2020.
  • Prelude Capital Management's portfolio value rose 22% quarter-over-quarter to $1.82B.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.